Tackling the global impact of substandard and falsified and unregistered/unlicensed anti-tuberculosis medicines.

Autor: Akpobolokemi T; Institute of Pharmaceutical Science, School of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences & Medicine, King's College London, London, UK., Martinez-Nunez RT; Department of Infectious Diseases, School of Immunology & Microbial Sciences, Faculty of Life Sciences & Medicine, King's College London, Guy's Hospital, London, UK., Raimi-Abraham BT; Institute of Pharmaceutical Science, School of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences & Medicine, King's College London, London, UK.

Publikováno v: The journal of medicine access [J Med Access] 2022 Jan 23; Vol. 6, pp. 23992026211070406. Date of Electronic Publication: 2022 Jan 23 (Print Publication: 2022).